Renasant Bio
PrivateLast Round
Seed
Jul 10, 2025
Total Funding Raised
$54.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Renasant Bio is a biopharmaceutical company developing oral small molecule corrector and potentiator therapies to target the underlying biology of autosomal dominant polycystic kidney disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renasant Bio Comparables
Compare Renasant Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mironid | 84% | |
| Vertex Pharmaceuticals | 74% | |
| Otsuka Holdings | 73% |
Renasant Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 10, 2025 |
Renasant Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Seed |
| 5AM Ventures | Seed |
| Qiming | Seed |
| Atlas Venture | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 159% MoM.
- Jul 2, 2026
Grew 18% QoQ, from 28 to 33 employees.
Renasant Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Renasant Bio's valuation, stock price, and market status.
Is Renasant Bio a public or private company?
Renasant Bio is a private company.
What is the current stock price of Renasant Bio?
Renasant Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Renasant Bio worth (valuation)?
Valuation information for Renasant Bio is not publicly available.
Can I buy Renasant Bio stock?
Renasant Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Renasant Bio's last funding round?
Renasant Bio's most recent funding round was Seed on July 10, 2025.
Who are the main investors in Renasant Bio?
Key investors in Renasant Bio include 5AM Ventures.
Will Renasant Bio IPO soon?
No public IPO plans have been announced for Renasant Bio.
How can I track Renasant Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Renasant Bio's secondary market activity and sign up for updates.